Alterations of cerebral glutamate in the euthymic state of patients with bipolar disorder

Psychiatry Research - Neuroimaging

Volumn 233, Issue 2, 2015, Pages 73-80

  Ehrlich, André ^a   Schubert, Florian ^b   Pehrs, Corinna ^c   Gallinat, Jürgen ^d  

^a MARTIN LUTHER KRANKENHAUS   (Germany)

^b PHYSIKALISCH TECHNISCHE BUNDESANSTALT   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Anterior cingulate cortex; Bipolar disorder; Glutamate; Hippocampus; Magnetic resonance spectroscopy (MRS)

Indexed keywords

CHOLINE; GLUTAMIC ACID; N ACETYLASPARTIC ACID; ASPARTIC ACID; N-ACETYLASPARTATE;

ADULT; ANTERIOR CINGULATE; ARTICLE; BIPOLAR DISORDER; BRAIN LEVEL; BRAIN METABOLISM; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; MALE; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSTERIOR COMMISSURE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; YOUNG MANIA RATING SCALE; ANALOGS AND DERIVATIVES; CINGULATE GYRUS; METABOLISM; MIDDLE AGED; PROCEDURES;

ADULT; ASPARTIC ACID; BIPOLAR DISORDER; CHOLINE; FEMALE; GLUTAMIC ACID; GYRUS CINGULI; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; PROTON MAGNETIC RESONANCE SPECTROSCOPY;

EID: 84938751614     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2015.05.010     Document Type: Article

References (74)

1. Ahmad S., Fowler L.J., Whitton P.S. Effects of combined lamotrigine and valproate on basal and stimulated extracellular amino acids and monoamines in the hippocampus of freely moving rats. Naunyn Schmiedeberg's Arch. Pharmacol. 2005, 371:1-8.
2. Amaral J.A., Tamada R.S., Issler C.K., Caetano S.C., Cerri G.G., Castro C.C., Lafer B. A HMRS study of the anterior cingulate gyrus in euthymic bipolar patients. Hum. Psychopharmacol. 2006, 21:215-220.
3. Anderson I.M., Haddah P.M., Scott J. Bipolar Disorder. BMJ 2012, 345:e8508.
4. Atmaca M., Yildirim H., Ozdemir H., Poyraz A.K., Tezcan E., Ogur E. Hippocampal (1) H MRS in first episode bipolar I patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30:1235-1239.
5. Atmaca M., Yildirim H., Ozdemir H., Ogur E., Tezcan E. Hippocampal (1) H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine. Psychol. Med. 2007, 37:121-129.
6. Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., Krystal J.H. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 2000, 47:351-354.
7. Bertolino A., Frye M., Callicott J.H., Mattay V.S., Rakow R., Shelton-Repella J., Post R., Weinberger D.R. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol. Psychiatry 2003, 53:906-913.
8. Bhagwagar Z., Wylezinska M., Jezzard P., Evans J., Ashworth F., Sule A., Matthews P.M., Cowen P.J. Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol. Psychiatry 2007, 61:806-812.
9. Blasi G., Bertolino A., Brudaglio F., Sciota D., Altamura M., Antonucci N., Scarabino T., Weinberger D.R., Nardini M. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton MRS imaging study. Psychiatry Res.: Neuroimaging 2004, 131:95-105.
10. Bora E., Fornito A., Yücel M., Pantelis C. Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol. Psychiatry 2010, 76:1097-1105.
11. Brambilla P., Stanley J.A., Nicoletti M.A., Sassic R.B., Mallinger A.G., Frank E., Kupfer D., Keshavan M.S., Soares J.C. H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. J. Affect. Disord. 2005, 86:61-67.
12. Chitty K.M., Lagopoulos J., Lee R.S., Hickie I.B., Hermens D.F. A systematic review and meta-analysis of proton magnetic resonance spectroscopy and mismatch negativity in bipolar disorder. Eur. Neuropsychopharmacol. 2013, 23:1348-1363.
13. Chuang D.-M., Chen R.-W., Chalecka-Franaszek E., Ren M., Hashimoto R., Senatorov V., Kanai H., Hough C., Hiroi T., Leeds P. Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord. 2002, 4:129-136.
14. Clark J.F., Doepke A., Filosa J.A., Wardle R.L., Lu A., Meeker T.J., Pyne-Geithman G.J. N-Acetylaspartate as a reservor for glutamate. Med. Hypotheses 2006, 67:506-512.
15. Colla M., Schubert F., Bubner M., Heidenreich J.O., Bajbouj M., Seifert F., Luborzewski A., Heuser I., Kronenberg G. Glutamate as a spectroscopic marker of hippo-campal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol. Mol. Psychiatry 2009, 14:696-704.
16. Dager S., Friedman S., Parow A., Demopulos C., Stoll A.L., Lyoo I.K., Dunner D.L., Renshaw P.F. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch. Gen. Psychiatry 2004, 61:450-458.
17. Danielsen E.R., Henriksen O. Absolute quantitative proton NMR spectroscopy based on the amplitude of the local water suppression pulse. Quantification of brain water and metabolites. NMR Biomed. 1994, 7:311-318.
18. Davanzo P., Thomas M.A., Yue K., Oshiro T., Belin T., Strober M., McCracken J. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 2001, 24:359-369.
19. Deicken R., Pegues M.P., Anzalone S., Feiwell R., Soher B. Lower concentrations of hippocampal N-acetylaspartate in familial bipolar I disorder. Am. J. Psychiatry 2003, 160:873-882.
20. Dong X., Wang Y., Qin Z. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol. Sin. 2009, 30:379-387.
21. Drevets W.C., Savitz J., Trimble M. The subgenual anterior cingulate cortex in mood disorders. CNS Spectr. 2008, 13:663-681.
22. Du J., Suzuki K., Wie Y., Wang Y., Blumenthal R., Chen Z., Falke C., Zarate C.A., Manji H.K. The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders. Neuropsychopharmacology 2007, 32:793-802.
23. Elster C., Schubert F., Link A., Walzel M., Seifert F., Rinneberg H. Quantitative magnetic resonance spectroscopy: semi-parametric modeling and determination of uncertainties. Magn. Reson. Med. 2005, 53:1288-1296.
24. Fornito A., Malhi G.S., Lagopoulos J., Ivanovski B., Wood S.J., Saling M.M., Pantelis C., Yücel M. Anatomical abnormalities of the anterior cingulate and paracingulate cortex in patients with bipolar I disorder. Psychiatry Res.: Neuroimaging 2008, 162:123-132.
25. 1H MRS study. Bipolar Disord. 2007, 9:119-127.
26. Friedman S.D., Dager S.R., Parow A., Hirashima F., Demopulos C., Stoll A.L., Lyoo I.K., Dunner D.L., Renshaw P.F. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biol. Psychiatry 2004, 56:340-348.
27. Frye M.A., Watzl J., Banakar S., O'Neill J., Mintz J., Davanzo P., Fischer J., Chirichigno J.W., Ventura J., Elman S., Tsuang J., Walot I., Thomas M.A. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology 2007, 32:2490-2499.
28. Gallinat J., Schubert F., Bruhl R., Hellweg R., Klar A.A., Kehrer C., Wirth C., Sander T., Lang U.E. Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex. Neuroimage 2009, 49:767-771.
29. Gigante A.D., Bond D.J., Lafer B., Lam R.W., Young L.T., Yatham L.N. Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Bipolar Disord. 2012, 14:478-487.
30. Haedel S., Wirth C., Rapp M., Gallinat J., Schubert F. Effects of age and sex on the concentrations of glutamate and glutamine in the human brain. J. Magn. Reson. Imaging 2013, 38:1480-1487.
31. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967, 6:278-296.
32. Hashimoto K., Sawa A., Iyo M. Increased levels of glutamate in brains from patients with mood disorders. Biol. Psychiatry 2007, 62:1310-1316.
33. Hassel B., Dingledine R. Glutamate. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects 2006, 267-290. Academic Press, San Diego. G.J. Siegel, R.W. Albers, S.T. Brady, D.L. Price (Eds.).
34. Heath P., Shaw P. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve 2002, 26:438-458.
35. Iosifescu D.V., Moore C.M., Deckersbach T., Tilley C.A., Ostacher M.J., Sachs G.S., Nierenberg A.A. Galantamine-ER for cognitive dysfunction in bipolar disorder and correlation with hippocampal neuronal viability: a proof-of-concept study. CNS Neurosci. Ther. 2009, 15(4):309-319.
36. Kaufman R.E., Ostacher M.J., Marks E.H., Simon N.M., Sachs G.S., Jensen J.E., Renshaw P.F., Pollack M.H. Brain GABA levels in patients with bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:427-434.
37. Knable M.B., Barci B.M., Webster M.J., Meador-Woodruff J., Torrey E.F. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol. Psychiatry 2004, 9:609-620.
38. Kraguljac N.V., Reid M.A., White D.M., Hollander J., Lahti A.C. Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia. Neuropsychopharmacology 2012, 37:2635-2642.
39. Lee W.T., Shen Y.Z., Chang C. Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy. Neuroscience 2000, 95:89-95.
40. Liu L., Schulz S.C., Lee S., Reutiman T.J., Fatemi S. Hippocampal CA1 pyramidal cell size is reduced in bipolar disorder. Cell. Mol. Neurobiol. 2007, 27:351-358.
41. Marx M.C., Billups D., Billups B. Maintaining the presynaptic glutamate supply for excitatory neurotransmission. J. Neurosci. Res., Electron. Publ. 2015, 10.1002/jnr.23561.
42. Matsuo K., Nicoletti M.A., Peluso M.A., Hatch J.P., Nemoto K., Watanabe Y., Nery F.G., Monkul E.S., Zunta-Soares G.B., Bowden C.L., Soares J.C. Anterior cingulate volumes associated with trait impulsivity in individuals with bipolar disorder. Bipolar Disord. 2009, 11:628-636.
43. Michael N., Erfurth A., Ohrmann P., Gossling M., Arolt V., Heindel W., Pfleiderer B. Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacology 2003, 168(3):344-346.
44. Michael N., Erfurth A., Pfleiderer B. Elevated metabolites within dorsolateral prefrontal cortex in rapid cycling bipolar disorder. Psychiatry Res.: Neuroimaging 2009, 172:78-81.
45. Michael-Titus A.T., Bains S., Jeetle R., Whelpton R. Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex - a possible mechanism of neuroprotection in major depression?. Neuroscience 2000, 100:681-684.
46. Moffett J.R., Ross B., Arun P., Madhavarao C.N., Namboodiri A.M.A. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog. Neurobiol. 2007, 81:89-131.
47. Moghaddam B. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J. Neurochem. 1993, 60:1650-1657.
48. Moore C.M., Frazier J.A., Glod C.A., Breeze J.L., Dieterich M., Finn C.T., Frederick B.D., Renshaw P.F. Glutamine and glutamate levels in children and adolescents with bipolar disorder: a 4.0-T proton magnetic resonance spectroscopy study of the anterior cingulate cortex. J Am. Acad. Child Adolesc. Psychiatry 2007, 46:524-534.
49. Moore G.J., Bebchuk J.M., Hasanat K., Chen G., Seraji-Bozorgzad N., Wilds I.B., Faulk M.W., Koch S., Glitz D.A., Jolkovsky L., Manji H.K. Lithium increases in N-acetylaspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?. Biol. Psychiatry 2000, 48:1-8.
50. Musazzi L., Treccani G., Mallei A., Popoli M. The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors. Biol. Psychiatry 2013, 73:1180-1188.
51. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. USA 1998, 95:13290-13295.
52. Ongur D., Jensen J.E., Prescot A.P., Stork C., Lundy M., Cohen B.M., Renshaw P.F. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol. Psychiatry 2008, 64:718-726.
53. Phillips M.L., Drevets W.C., Rauch S.L., Lane R. Neurobiology of emotion perception: I. The neural basis of normal emotion perception. Biol. Psychiatry 2003, 54:504-514.
54. Pittaluga A., Raiteri L., Longordo F., Luccini E., Barbiero V.S., Racagni G., Popoli M., Raiteri M. Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus. Neuropharmacology 2007, 53:27-36.
55. Port J.D., Unal S.S., Mrazek D.A., Marcus S.M. Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study. Psychiatry Res.: Neuroimaging 2008, 162:113-121.
56. Rao J., Harry G., Rapoport S., Kim H. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol. Psychiatry 2010, 15:384-392.
57. Sanacora G., Zarate C., Krystal J., Manji H. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat. Rev. Drug Discov. 2008, 7:426-437.
58. Sanacora G., Treccani G., Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012, 62:63-77.
59. Schubert F., Gallinat J., Seifert F., Rinneberg H. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3T. Neuroimage 2004, 21:1762-1771.
60. Schubert M., Kalisch R., Sotiropoulos I., Catania C., Sousa N., Almeida O.F.X., Auer D.P. Effects of altered corticosteroid milieu on rat hippocampal neurochemistry and structure: an in vivo magnetic resonance spectroscopy and imaging study. J. Psychiatry Res.: Neuroimaging 2008, 42:902-912.
61. Senaratne R., Milne A., MacQueen G., Hall G. Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: a proton magnetic resonance spectroscopy study. Psychiatry Res.: Neuroimaing 2009, 172:205-209.
62. Silverstone P.H., Wu R.H., O'Donnell T., Ulrich M., Asghar S.J., Hanstock C.C. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. Int. Clin. Psychopharmacol. 2003, 18(2):73-79.
63. Singh M., Spielman D., Adleman N., Alegria D., Howe M., Reiss A., Chang K. Brain glutamatergic characteristics of pediatric ospring of parents with bipolar disorder. Psychiatry Res.: Neuroimaging 2010, 182:165-171.
64. Soeiro-de-Souza M.G., Salvadore G., Moreno R.A., Otaduy M.C., Chaim K.T., Gattaz W.F., Zarate C.A., Machado-Vieira R. Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder. Neuropsychopharmacology 2013, 38(3):468-475.
65. Stork C., Renshaw P.F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol. Psychiatry 2005, 10:900-919.
66. Strawn J.R., Patel N.C., Chu W.J., Lee J.H., Adler C.M., Kim M.J., Bryan H.S., Alfieri D.C., Welge J.A., Blom T.J., Nandagopal J.J., Strakowski S.M., Delbello M.P. Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study. J. Am. Acad. Child Adolesc. Psychiatry 2012, 51:642-651.
67. Swayze V.W., Andreasen N.C., Alliger R.J., Yuh W.T., Ehrhardt J.C. Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study. Biol. Psychiatry 1992, 31:221-240.
68. 1H J-difference spectroscopy. Magn. Reson. Imaging 2011, 29:19-24.
69. Wang J.F., Shao L., Sun X., Young L.T. Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord. 2009, 11:523-529.
70. Wessa M., Linke J. Emotional processing in bipolar disorder: behavioural and neuroimaging findings. Int. Rev. Psychiatry 2009, 21(4):357-367.
71. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 1978, 133:429-435.
72. Yuksel C., Ongur D. Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biol. Psychiatry 2010, 68:785-794.
73. Zarate C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., Charney D.S., Manji H.K. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 2006, 63:856-864.
74. Zarate C.J., Singh J., Manji H. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol. Psychiatry 2006, 59:1006-1020.